| Document |
Document Title |
|
WO/2005/075157A1 |
The invention comprises a method of an industrial robot (), comprising a control unit () and a manipulator () including a tool () comprising a defined TCP and a device for determining a distance error (d*) between an inaccurately program...
|
|
WO/2005/075658A1 |
The present invention provides a process for the production of vitamin C from a substrate, such as for instance L-sorbosone using a microorganism belonging to the genus Ketogulonicigenium.
|
|
WO/2005/073387A2 |
The invention relates to a method for obtaining the molybdopterin derivative precursor Z, whereby an over-production of precursor Z occurs in host organisms by recombinant expression of precursor Z synthesizing proteins. The invention fu...
|
|
WO/2005/073389A1 |
The invention relates to a method for producing β-hydroxy nitro compounds of formula (I), in which R1 and R2, independent of one another, represent a C1-C20 alkyl radical, C6-C14 aryl radical, C1-C14-heteroaryl radical, optionally subst...
|
|
WO/2005/073223A1 |
A method of stabilizing a macrolide compound and a process for efficiently producing the compound. The method, which is for stabilizing a 12-membered cyclic macrolide compound, e.g., that represented by the formula (I), comprises causing...
|
|
WO/2005/073388A1 |
A process for producing an optically active 1,4-pentanediol which comprises asymmetrically reducing 5-hydroxy-2-pentanone, which is easily available at low cost. Also provided is a process for producing an optically active 1-substituted ...
|
|
WO/2005/072711A2 |
The invention relates to an improved method for cultivating the fungus Penicillium chrysogenum, especially strain KIP 3201, for producing the antitumoral natural substance Sorbicillactone A of formula (I) and its derivatives in an optimi...
|
|
WO/2005/069849A2 |
The present invention provides an improved process for producing a fermentation product in a fermentation medium, including ethanol, which process include a fermentation step, comprising subjecting the fermentation medium to at least one...
|
|
WO/2005/066353A1 |
The invention relates to a device for enzymatically producing baccatin III in an enzyme reactor (R). To this end, the enzyme reactor (R) comprises a hollow fiber ultrafiltration membrane (M), and an acetyl transferase from Taxus spec. is...
|
|
WO/2005/063740A1 |
The present invention relates a novel compound, chrysogenazine containing both indole and diketopiperazine ring systems, isolated from the chloroform fraction of the fermentation broth of Penicillium chrysogenum and the gross structure o...
|
|
WO/2005/064006A1 |
The present invention relates to optically active heteroaromatic β -hydroxy esters of formula (I) useful in the synthesis of epothilone derivatives, to beta-keto esters of formula (IV) used to produce these intermediates by means of an ...
|
|
WO/2005/063963A1 |
The present invention relates to a tacrolimus producing strain, more precisely, a Streptomyces clavuligerus strain mass-producing tacrolimus represented by formula 1 and a method for mass-production of tacrolimus by using the same. The s...
|
|
WO2004100649B1 |
Plant material enriched in secondary metabolites is produced in tissue culture under conditions that organogenically produce a proliferation of shoots and leafy material, and harvesting the leafy material and shoots while in a green, act...
|
|
WO/2005/064002A1 |
The present invention relates to a method for mass production of secondary metabolites in plant cell culture, more specifically, to a method for production of secondary metabolites comprising the step of culturing plant cells in a medium...
|
|
WO/2005/061461A1 |
Inhibitors against members of the heat shock protein 90 (hsp90) family, containing as the active ingredient benzenoid ansamycin derivatives represented by the general formula (I) which are useful as antitumor drug or other drugs or pharm...
|
|
WO/2005/059152A1 |
A method of oxidising carbohydrates and/or carbohydrate derivatives having primary alcohol groups comprising contacting a reaction medium containing said carbohydrates and/or carbohydrate derivatives with a nitroxy radical mediator and a...
|
|
WO/2005/054266A2 |
14-membered macrolide compounds such as erythromycins are provided with functional groups at the 14- and/or 15-position by providing a 14-membered aglycone template and feeding it to a strain capable of hydroxylating it at the 14 and/or ...
|
|
WO/2005/054250A1 |
The invention relates to tricyclacetalactonin, preparation and use there of. Said tricyclacetalactonin is prepared from Streptomyces albogriseolus of A2-2002. As being proved by the experiments, said compounds can be used as cell cycle i...
|
|
WO/2005/053678A1 |
Therapeutic or preventive agents for ischemic neuropathy containing as the active ingredient compounds represented by the general formula [2]: wherein R1 and R4 are each independently hydrogen, carboxy, or alkoxycarbonyl; and R2 and R5 a...
|
|
WO/2005/054491A1 |
A process for producing (R)-tetrahydrothiophen-3-ol, comprising the step (A) of incubating tetrahydrothiophen-3-one in the presence of a preparation of strain belonging to the genus Penicillium, the genus Aspergillus or the genus Strepto...
|
|
WO/2005/054186A2 |
The present invention relates to methods of preparing a stereoisomerically enriched compound of formula (I), wherein R6 is hydrogen, comprising treating a compound of formula (I), wherein R6 is chosen from C1-C10 alkyl, C2-C10 alkenyl, C...
|
|
WO/2005/052152A1 |
It is intended to provide a DNA participating in the hydroxylation of a macrolide compound 11107B and a novel method of producing a macrolide compound 11107D. More specifically speaking, a DNA participating in the biological conversion o...
|
|
WO/2005/047275A1 |
The invention relates to 2-phenyl-benzofuran compounds of formula (I), which are formed by the microorganism Aspergillus flavipes ST003878 (DSM 15290) during fermentation, to a method for the production thereof and to their use as medica...
|
|
WO/2005/047509A2 |
The present invention relates to Mycobacterium ulceran virulence plasmid, pMUM001 and particularly to a cluster of genes carried by this plasmid that encode polyketide synthases (PKSs) and polyketide-modifying enzymes necessary and suffi...
|
|
WO/2005/045051A1 |
The present invention relates to a method for de-glycosylation of baicalin to produce baicalein by treating the baicalin with an enzyme having beta-glucuronidase activity under conditions such that baicalin is converted to baicalein.
|
|
WO/2005/044803A1 |
The invention relates to bengamide derivatives which are formed by the micro-organism Myxococcus virescens ST200611 (DSM 15898), during fermentation, to the use thereof for the treatment of cancer, to medicaments containing bengamide der...
|
|
WO/2005/042720A2 |
Disclosed are strains of Vibrio sp bacteria that produce kahalalides or derivatives thereof, methods of isolating said strains, and 16S rRNA sequences useful in identifying kahalalides producing bacteria.
|
|
WO/2005/042757A1 |
The present invention relates to a method for preparing a Sohporae Fructus extract containing isoflavone. More particularly, the present invention relates to a method for preparing a Sohporae Fructus extract containing isoflavone in high...
|
|
WO/2005/042756A2 |
Methods and compositions that can be used to make monatin or salt thereof from glucose, tryptophan, indole-3-lactic acid, indole-3-pyruvate, and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid, are provided. Methods are also disclose...
|
|
WO/2005/040373A1 |
Polyacrylamide beads containing encapsulated cells were prepared by a process comprising the steps of (i) providing an aqueous solution of a mixture of acrylic monomers, (ii) providing a suspension of cells in an aqueous solution of a pe...
|
|
WO/2005/040107A2 |
The invention provides synthetic chemical and chemoenzymatic methods of producing simvastatin and various intermediates. In one aspect, enzymes such as hydrolases, e.g., esterases, are used in the methods of the invention.
|
|
WO/2005/037813A1 |
The invention relates to a new compound, to the preparation thereof, and to the use of which in the preparation of a drug as a calcium antagonist of L type channel. The compound of the invention is very important in the treatment of hear...
|
|
WO/2005/038036A1 |
The invention relates to a method for hydrolysing fluorinated epoxy comprising one or several CF3 groups consisting in treating an epoxy in the presence of a protein exhibiting epoxy hydrolysis (EH) activity with respect to CF3 epoxies i...
|
|
WO/2005/038009A2 |
The invention relates to a new microorganism Streptomyces glaucescens MTCC 5115 and a process for producing the immunosuppressant agent, tacrolimus (FK-506) utilizing the new microorganism Streptomyces glaucescens MTCC 5115. The inventio...
|
|
WO/2005/038008A1 |
The present invention relates to a method for preparing a fermentation product of soybean having an enhanced content of #-aminobutyric acid and phytoestrogens by using the Bifidobacterium breve K-110, said method comprising the steps of ...
|
|
WO/2005/033076A1 |
This invention relates to a method of preparing (3R,4R)-3-hydroxy-4-hydroxymethylpyrrolidine, a key intermediate compound for the synthesis of certain inhibitor compounds, including the step of enzyme catalysed enantioselective esterific...
|
|
WO/2005/033305A1 |
A process for producing an intermediate of alkaloid biosynthesis, comprising inhibiting the expression of an enzyme using a target alkaloid biosynthesis intermediate as a substrate by the employment of RNAi method in an alkaloid producin...
|
|
WO/2005/030944A1 |
The present invention provides an enzyme that catalyzes the reaction producing piperitol from pinoresinol, and a reaction producing sesamin from piperitol. The invention also provides a gene that encodes such enzyme. Further, the inventi...
|
|
WO/2005/026373A1 |
The present invention relates to a process for the preparation of enantiopure intermediates useful in the synthesis of valuable pharmaceutically active compounds, e.g. MAOB inhibitors, and to novel intermediates of formulae (I) and (II) ...
|
|
WO/2005/025490A2 |
A novel family of cyclic polyene natural products isolated from marine actinomycete strain CNQ 140 is provided. This novel strain of actinomycetes was obtained from a previously unstudied population of marine actinomycetes that reside in...
|
|
WO/2005/024025A1 |
Novel polyene polyketides, their pharmaceutically acceptable salts, prodrugs and derivatives have been found to have antibiotic activity. Formula (I) One method for obtaining the compounds is by cultivation of Amycolatopsis orientalis AT...
|
|
WO/2005/023788A1 |
A microorganism belonging to Beauveria sp. and being capable of producing FKI-1366 substance A and/or FKI-1366 substance B and/or FKI-1366 substance C (Beauveria sp. FKI-1366, FERM BP-08459) is cultured in a medium and thus the FKI-1366 ...
|
|
WO/2005/020883A2 |
A process of the large-scale fermentation of a highly productive ansamitocin-producing strains. A method for isolating crude ansamitocins. A method for purifying ansamitocins.
|
|
WO/2005/021586A2 |
The invention provides a nucleic acid molecule comprising at least a functional fragment of the viomycin biosynthetic gene cluster, functional proteins encoded by the cluster, expression cassettes and recombinant host cells comprising a ...
|
|
WO2004089958B1 |
Provided is a method for crystallization and purification of a macrolide such as tacrolimus, sirolimus, pimecrolimus, or everolimus that includes the step of providing a combination of a macrolide, and a polar solvent, dopolar aprotic so...
|
|
WO/2005/019426A2 |
Domains of fostriecin polyketide synthase and modification enzymes and polynucleotides encoding them are provided. Methods to prepare fostriecin in pharmaceutically useful quantities are described, as are methods to prepare fostriecin an...
|
|
WO/2005/017099A2 |
The present invention relates to engineering metabolic pathways in bacterial host cells which results in enhanced carbon flow for the production of ascorbic acid (ASA) intermediates. In particular, the invention relates to increasing the...
|
|
WO/2005/017159A2 |
The present invention discloses an isolated polynucleotide molecule derived from a polynucleotide encoding a polypeptide having L-sorbosone dehydrogenase activity comprising a partial nucleotide sequence of at least 20 consecutive nucleo...
|
|
WO/2005/016851A1 |
The invention relates to novel molecules and libraries thereof as well as methods for their production. Methods of producing the novel molecules include a. cleaving one or more of starting molecules into molecular subunits ; and b. assem...
|
|
WO/2005/017172A1 |
The present invention relates to a novel process for the production of L-ascorbic acid in high yields by using resting cells of a microorganism able to convert given carbon sources into vitamin C. The thus obtained vitamin C may be furth...
|
